Early research (Phase 1)Not Yet RecruitingNCT07406347
What this trial is testing
A Trial to Evaluate the Safety and Reactogenicity of an Investigational Pneumococcal Vaccine in Infants Receiving 3-dose Primary Dosing Series Followed by a Booster Dose at 12 to 15 Months of Age
Who this might be right for
Pneumonia, Bacterial
GlaxoSmithKline 60